Flagship explainer
What drives TEVA PHARMACEUTICAL INDUSTRIES LIMITED’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $1.4B | FY2025 |
| |
| Income before tax | $1.2B | FY2025 |
|
| Operating income | $2.2B | FY2025 |
|
| $17.3B | FY2025 |
| |
| Ending assets | $40.7B | FY2025 |
|
| Beginning assets | $39.3B | FY2024 |
|
| $7.9B | FY2025 |
| |
| $5.4B | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-25-020826
- SEC filingFiling detailsAccession 0001193125-26-034532